Uncommon Therapeutics is a disease-focused biotech developing multiple high-value therapeutics per disease by combining cutting-edge tools with deep disease expertise to deliver cures
Uncommon Therapeutics is a disease-focused biotech developing multiple high-value therapeutics per disease by combining cutting-edge tools with deep disease expertise to deliver cures. They are initially targeting Rett Syndrome, a severe genetic disease affecting 1 in 10,000 female births, with plans to expand to other rare diseases.